can you microdose glp-1 Thinking About Microdosing GLP-1? 5 Myths Debunked | Live Healthy Microdosing GLP-1s: How (and Why)

Unlike the original diabetic patient population, many off-label users are younger, healthier individuals without the metabolic dysfunction that might warrant acceptance of serious side effect risks

Real-World Study Findings The study included adults with overweight or obesity without type 2 diabetes who had continuous treatment for one year: Semaglutide (Wegovy) Results: Patients achieved an average weight loss of 14.1% after one year Tirzepatide Results: Patients achieved an average weight loss of 16.5% after one year These real-world results closely mirror the clinical trial findings, demonstrating that the superior weight loss seen with tirzepatide in controlled studies translates to actual patient care settings

Why provider matters more than medication GLP-1s are powerful medications

By early 2026 the global standard for body transformation has moved beyond the simple discipline vs